Paul H. Lipkin, M.D.

Headshot of Paul H. Lipkin
  • Professor of Pediatrics

Research Interests

Developmental disabilities in infants and children; Autism spectrum disorders; Attention deficit hyperactivity disorder (ADHD); Learning disorders; Intellectual disabilities; Neurodevelopmental outcomes in children with congenital heart disease more


Dr. Paul H. Lipkin is an associate professor of pediatrics at the Johns Hopkins University School of Medicine. Dr. Lipkin’s clinical interests include developmental concerns such as autism and attention, learning, and language disorders. He treats infants and children at the Kennedy Krieger Institute’s Center for Development and Learning and is on the faculty of the Institute’s Maternal and Child Health Leadership Education in Neurodevelopmental and Other Related Disabilities (LEND) Program.

As director of medical informatics at the Kennedy Krieger Institute, Dr. Lipkin oversees the Interactive Autism Network (IAN) and related clinical and research informatics services, connecting those affected by autism and other developmental disorders with researchers throughout the world.

Dr. Lipkin received his undergraduate degree from Rutgers University and attended medical school at the University of Medicine and Dentistry of New Jersey - New Jersey Medical School. He received his general pediatric training, focusing on primary care, at Sinai Hospital of Baltimore, followed by subspecialty training in developmental pediatrics at Johns Hopkins University and the Kennedy Krieger Institute. Dr. Lipkin joined the faculty of the Kennedy Krieger Institute and Johns Hopkins University in 1995.

He has provided national leadership on autism and other developmental disorders through his work with the American Academy of Pediatrics (AAP), which recognized him with the 2011 Arnold J. Capute Award to honor his contributions to the field of developmental disabilities. He was also awarded a prestigious Robert Wood Johnson Foundation Health Policy Fellowship, which he completed in the U.S. Department of Health and Human Services’ Office of the Secretary in 2011.

Dr. Lipkin is a former chair of the Council on Children with Disabilities and currently leads key AAP initiatives on early developmental surveillance and screening. more


  • Professor of Pediatrics

Departments / Divisions



  • M.D.; Rutgers New Jersey Medical School (New Jersey) (1981)

Additional Training

  • American Board of Pediatrics / Pediatrics
  • American Board of Pediatrics / Neurodevelopmental Disabilities
  • American Board of Pediatrics / Developmental-Behavioral Pediatrics

Research & Publications

Research Summary

Dr. Lipkin is the principal investigator of the Interactive Autism Network (IAN), where he leads a team of Kennedy Krieger Institute researchers in a program that connects patients and families with medical researchers throughout the world.

His career also has focused on the early identification and treatment of neurodevelopmental disorders in infants and children.

Dr. Lipkin is active in initiatives centered on developmental and autism screening in the general population, as well as in high-risk children, such as those with congenital heart diseases and motor disorders.

He has served on consensus panels on the neurodevelopmental evaluation of children exposed in utero to alcohol and other prenatal and environmental toxins.

Selected Publications

Lipkin PH. “Methylphenidate reduces ADHD symptoms in children with severe ADHD and intellectual disability.” Evid Based Ment Health. 2013 Nov;16(4):104. doi: 10.1136/eb-2013-101454. Epub 2013 Aug 30.

Marino BS, Lipkin PH, Newburger JW, Peacock G, Gerdes M, Gaynor JW, Mussatto KA, Uzark K, Goldberg CS, Johnson WH Jr, Li J, Smith SE, Bellinger DC, Mahle WT; American Heart Association Congenital Heart Defects Committee, Council on Cardiovascular Disease in the Young, Council on Cardiovascular Nursing, and Stroke Council. “Neurodevelopmental outcomes in children with congenital heart disease: evaluation and management: a scientific statement from the American Heart Association.” Circulation. 2012 Aug 28;126(9):1143-72. Epub 2012 Jul 30.

Lipkin PH. “Lessons and opportunities from autism screening in high-risk children.” Dev Med Child Neurol. 2012 Jun;54(6):485. doi: 10.1111/j.1469-8749.2012.04285.x. Epub 2012 Mar 28.

Lipkin PH, Hyman SL. “Should all children be screened for autism spectrum disorders? Yes: merging science, policy, and practice.” Am Fam Physician. 2011 Aug 15;84(4):361-7.

Rimrodt SL, Lipkin PH. “Learning disabilities and school failure.” Pediatr Rev. 2011 Aug;32(8):315-24. doi: 10.1542/pir.32-8-315.

Activities & Honors


  • Arnold J. Capute Award, American Academy of Pediatrics, 2011
  • Health Policy Fellow, (U.S. Department of Health and Human Services’ Office of the Secretary), Robert Wood Johnson Foundation, 2010 - 2011
Is this you? Edit Profile
back to top button